Tick-Borne Disease Working Group Special Issue SECTION
Tick-Borne Disease Working Group Special Issue
Overview of the Tick-Borne Disease Working Group: What Has Been Accomplished so Far?
TBDWG subcommittees have been working nearly around the clock to ensure high-integrity reports will be ready for submission to Congress later this year and will include the most comprehensive viewpoints possible.
How the Patient Voice Has Impacted the Tick-Borne Disease Working Group
Patients are coming together to have an impact and create change in Lyme disease policy. The patient voice has a powerful impact on the future of Lyme.
LymeDisease.org founder, Phyllis Mervine shares her story of growing up in Lyme-endemic areas, and then contracting Lyme disease in Mendocino County, California.
Lyme Disease Costs May Exceed $75 Billion per Year
The CDC’s recent increase in estimated Lyme disease cases per year means we also need to update how we view real-world economic costs for Lyme patients.
How the LYMErix Lyme Disease Vaccine was Pulled from the Market
Patricia Smith, president of LDA, identifies lessons we can learn from the LYMErix Lyme disease vaccine story and pitfalls we can hopefully avoid in the future.